DIN 02458020 — DOCETAXEL INJECTION 20 MG
DOCETAXEL INJECTION is a solution of Docetaxel marketed by BIOLYSE PHARMA CORPORATION. The full Docetaxel monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02458020
- Brand name
- DOCETAXEL INJECTION
- Active ingredient
- Docetaxel
- Strength
- 20 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- BIOLYSE PHARMA CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Taxane antineoplastic agent (microtubule inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Docetaxel products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02439336 | DOCETAXEL INJECTION | 10 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02437031 | DOCETAXEL INJECTION | 20 MG | SOLUTION | ACCORD HEALTHCARE INC | DORMANT |
| 02361957 | DOCETAXEL INJECTION USP | 10 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |